1. [1,2]-C-14-Ethylene glycol (EG) was given to female CD (Sprague-Dawley) rats and CD-1(R) mice in order to determine tissue distribution and metabolic fate after intravenous (iv), peroral (po), and percutaneous (pc) doses. Rats were given doses of 10 or 1000 mg/kg by each route, and additional po doses of 400, 600 or 800 mg/kg. Mice were also given iv and po doses of 10 or 1000 mg/kg, and intermediate po doses of 100, 200 or 100 mg/kg. Mice were given pc doses of 100 or 1000 mg/kg, and both species were given a 50 % (w/w) aqueous pc dose to simulate antifreeze exposure. 2. For both species, EG is very rapidly and almost completely adsorbed after po doses. Perorally administered EG doses produced similar dose-dependent relationships described in prior studies for the disposition and excretion of iv doses. 3. The tissue distribution of EG following either iv or po routes was essentially the same, with similar percentages recovered for each dose by both routes and for either species. 4. Cutaneously-applied EG was slowly and rather poorly adsorbed in both species, in comparison with po dose administration, and urinalysis after undiluted pc doses indicated that EG probably penetrates rat shin in the parent form. There was an absence in both species of dose-dependent changes in disposition and elimination following the pc application of EG. 5. C-14-labelled EG, glycolic acid and/or oxalic acid accounted for the majority of the detectable radioactivity in the urine samples from all dose routes in the rat, while glycoaldehyde and glyoxylic acid were not detected in any of the urine fractions evaluated. Similar increases in glycolate production with increasing dose were also observed in mouse urine samples from iv and po dosing. Also, glyoxylate and oxalate were absent from mouse urine. 6. Oxidative metabolic pathways appeared to be saturated at high po doses in both species, resulting in a shift from principally (CO2)-C-14 exhalation to urinary C-14 excretion, while the onset of capacity-limited metabolic changes appears to occur at lower doses for mice than for rats.
